Vertex Pharmaceuticals Inc (VRTX)
393.48
+0.38
(+0.10%)
USD |
NASDAQ |
Apr 18, 16:00
393.52
+0.04
(+0.01%)
After-Hours: 20:00
Vertex Pharmaceuticals Price to Book Value: 5.781 for April 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 5.781 |
| April 17, 2024 | 5.776 |
| April 16, 2024 | 5.792 |
| April 15, 2024 | 5.838 |
| April 12, 2024 | 5.826 |
| April 11, 2024 | 5.881 |
| April 10, 2024 | 5.842 |
| April 09, 2024 | 5.943 |
| April 08, 2024 | 5.939 |
| April 05, 2024 | 5.975 |
| April 04, 2024 | 5.936 |
| April 03, 2024 | 6.007 |
| April 02, 2024 | 6.016 |
| April 01, 2024 | 6.178 |
| March 28, 2024 | 6.142 |
| March 27, 2024 | 6.132 |
| March 26, 2024 | 6.148 |
| March 25, 2024 | 6.113 |
| March 22, 2024 | 6.107 |
| March 21, 2024 | 6.108 |
| March 20, 2024 | 6.055 |
| March 19, 2024 | 6.100 |
| March 18, 2024 | 6.044 |
| March 15, 2024 | 5.990 |
| March 14, 2024 | 6.006 |
| Date | Value |
|---|---|
| March 13, 2024 | 6.071 |
| March 12, 2024 | 6.060 |
| March 11, 2024 | 6.090 |
| March 08, 2024 | 6.077 |
| March 07, 2024 | 6.032 |
| March 06, 2024 | 6.051 |
| March 05, 2024 | 6.104 |
| March 04, 2024 | 6.230 |
| March 01, 2024 | 6.358 |
| February 29, 2024 | 6.182 |
| February 28, 2024 | 6.273 |
| February 27, 2024 | 6.332 |
| February 26, 2024 | 6.369 |
| February 23, 2024 | 6.320 |
| February 22, 2024 | 6.271 |
| February 21, 2024 | 6.166 |
| February 20, 2024 | 6.180 |
| February 16, 2024 | 6.203 |
| February 15, 2024 | 6.264 |
| February 14, 2024 | 6.140 |
| February 13, 2024 | 6.113 |
| February 12, 2024 | 6.149 |
| February 09, 2024 | 6.214 |
| February 08, 2024 | 6.201 |
| February 07, 2024 | 6.143 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.758
Minimum
Oct 05 2021
11.87
Maximum
Jun 23 2020
7.105
Average
6.227
Median
Price to Book Value Benchmarks
| Amgen Inc | 22.60 |
| Eli Lilly and Co | 65.84 |
| Regeneron Pharmaceuticals Inc | 3.776 |
| Alpine Immune Sciences Inc | 12.88 |
| Moderna Inc | 2.819 |
Price to Book Value Related Metrics
| PE Ratio | 28.33 |
| PS Ratio | 10.39 |
| PEG Ratio | 3.429 |
| Price to Free Cash Flow | 31.26 |
| Price | 393.48 |
| Earnings Yield | 3.53% |
| Market Cap | 101.64B |
| PEGY Ratio | 3.429 |
| Operating PE Ratio | 23.80 |
| Normalized PE Ratio | 25.66 |